Sign in

CIK 0001601830

  • Large accelerated filer

RECURSION PHARMACEUTICALS, INC.

Sign in to watch
Ticker
RXRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464099738
Phone
+1 385-269-0203
Business address
41S RIO GRANDE STREET, SALT LAKE CITY, UT, 84101
Former names
Recursion Pharmaceuticals, LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$701,222
in 5 filings, $701K under 10b5-1 plans

Net −$701,222. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-01-16 Virani Shafique Chief Business Officer Exercise or conversion 10b5-1 +18,000 $2.22 $40K 154,748
2024-01-16 Virani Shafique Chief Business Officer Sale 10b5-1 −18,000 $10.93 $197K 136,748
2024-01-16 Virani Shafique Chief Business Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −18,000 361,469
2024-01-16 Secora Michael Chief Financial Officer Exercise or conversion 10b5-1 +37,500 $2.22 $83K 993,514
2024-01-16 Secora Michael Chief Financial Officer Sale 10b5-1 −25,000 $10.45 $261K 968,514
2024-01-16 Secora Michael Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −37,500 1,072,635
2024-01-09 Li Dean Y Director Sale 10b5-1 −28,038 $13.65 $383K 421,962
2024-01-09 Li Dean Y Director Sale 10b5-1 −962 $14.03 $13K 421,000
2024-01-09 Borgeson Blake Director Sale 10b5-1 −6,303 $13.21 $83K 7,358,169
2024-01-09 Borgeson Blake Director Sale 10b5-1 −13,751 $13.81 $190K 7,344,418
2024-01-03 Gibson Christopher Chief Executive Officer Conversion +10,000 801,328
2024-01-03 Gibson Christopher Chief Executive Officer Gift −10,000 791,328
2024-01-03 Gibson Christopher Chief Executive Officer Exercise or conversion +31,250 $2.48 $78K 822,578
2024-01-03 Gibson Christopher Chief Executive Officer Sale −30,853 $9.49 $293K 791,725
2024-01-03 Gibson Christopher Chief Executive Officer Conversion +4,000 4,000
2024-01-03 Gibson Christopher Chief Executive Officer Sale −4,000 $9.51 $38K 0
2024-01-03 Gibson Christopher Chief Executive Officer Conversion +20,000 20,000
2024-01-03 Gibson Christopher Chief Executive Officer Sale −20,000 $9.51 $190K 0
2024-01-03 Gibson Christopher Chief Executive Officer Conversion +1,000 1,000
2024-01-03 Gibson Christopher Chief Executive Officer Sale −1,000 $9.49 $9K 0

Page 26 of 41 · 805 trades